Some cookies are essential to the running of the website, while others (analytics) help us to make improvements. We also incorporate functionality from other websites, such as video, social media feeds and ReachDeck (text-to-speech and translations services) which may set cookies. More on how we use cookies
This website uses text-to-speech software called ReachDeck to read and / or translate its content. To use ReachDeck, you must allow ReachDeck cookies; the ReachDeck icon will then appear at the bottom right of your screen.
You can find out more about how ReachDeck uses cookies or change your cookie preferences at any time by going to our cookies page.
Allow ReachDeck cookies Do not use ReachDeck
If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).
Please find information on our services and visiting restrictions in our COVID-19 section.
Patients and visitors must wear a face covering in our hospitals.
This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.
Regulations require that clinical trials be adequately monitored for GCP compliance by a suitably trained/qualified monitor. However, monitoring of non-commercial trials does not always need the intensity traditionally employed by the pharmaceutical industry.
The R&D team can provide monitoring, or help you find an appropriate monitor. It is essential that monitoring costs are included in funding applications.